Fed Policy Disagreements Hinder Morgan Stanley Exemption Approval

Summary

Internal policy rifts within the Federal Reserve, led by Vice Chair Michael Barr, significantly delayed Morgan Stanley’s waiver application for organizational restructuring [Sina Finance][Sina Finance]. While the majority eventually approved the waiver, Barr warned that using low-cost federal deposit insurance to fund high-risk activities sets a dangerous precedent [Sina Finance][Sina Finance]. This friction occurs despite Morgan Stanley’s strong Q1 2026 performance and its efforts to lobby for reduced capital requirements under revised Basel III rules [Reuters][Zhitong].

Impact Analysis

So the Fed is basically showing its teeth, even with the deregulation tailwinds from the administration. The delay on Morgan Stanley’s restructuring waiver isn’t just a procedural hiccup; it’s Michael Barr signaling that the ‘deregulation bonanza’ won’t be a slam dunk. While MS eventually got the green light, the friction confirms that using low-cost deposits to fund high-risk trading desks remains a massive red flag for the hawks [Sina Finance][Sina Finance].

This is a classic ‘narrative vs. reality’ check. The market wants to price in immediate capital relief, but this internal rift suggests a grinding, litigious process ahead for the G-SIBs. That said, MS is still crushing the fundamentals—record trading and an AI-driven IPO pipeline are real tailwinds [Tip Ranks][Zhitong]. I’d use any regulatory-driven dip to add to positions. The long-term play is the massive capital release once Basel III rules finally soften, which CFO Yeshaya is already telegraphing [Reuters][Reuters]. Bottom line: The path to $200+ is intact, just expect more turbulence than the bulls want to admit.